WO2003097072A9 - 肝斑改善用組成物及びくすみ改善用組成物 - Google Patents

肝斑改善用組成物及びくすみ改善用組成物 Download PDF

Info

Publication number
WO2003097072A9
WO2003097072A9 PCT/JP2003/006175 JP0306175W WO03097072A9 WO 2003097072 A9 WO2003097072 A9 WO 2003097072A9 JP 0306175 W JP0306175 W JP 0306175W WO 03097072 A9 WO03097072 A9 WO 03097072A9
Authority
WO
WIPO (PCT)
Prior art keywords
amelioration
chloasma
dullness
composition
nucleic acid
Prior art date
Application number
PCT/JP2003/006175
Other languages
English (en)
French (fr)
Other versions
WO2003097072A1 (ja
Inventor
Hideo Tanaka
Masahiko Tanaka
Yasuo Furuta
Kosaburo Wakamatsu
Junko Kamimura
Fumiki Harano
Mitsuaki Kawamura
Shigekatsu Kawabata
Shigeo Shinohara
Noboru Yoshino
Original Assignee
Otsuka Pharma Co Ltd
Hideo Tanaka
Masahiko Tanaka
Yasuo Furuta
Kosaburo Wakamatsu
Junko Kamimura
Fumiki Harano
Mitsuaki Kawamura
Shigekatsu Kawabata
Shigeo Shinohara
Noboru Yoshino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Hideo Tanaka, Masahiko Tanaka, Yasuo Furuta, Kosaburo Wakamatsu, Junko Kamimura, Fumiki Harano, Mitsuaki Kawamura, Shigekatsu Kawabata, Shigeo Shinohara, Noboru Yoshino filed Critical Otsuka Pharma Co Ltd
Priority to EP03728092.2A priority Critical patent/EP1512405B1/en
Priority to JP2004505070A priority patent/JP4425127B2/ja
Priority to AU2003234818A priority patent/AU2003234818B8/en
Priority to US10/514,833 priority patent/US7994153B2/en
Priority to BR0311154-7A priority patent/BR0311154A/pt
Priority to KR1020047018673A priority patent/KR100948684B1/ko
Priority to ES03728092T priority patent/ES2428027T3/es
Priority to CA2487789A priority patent/CA2487789C/en
Publication of WO2003097072A1 publication Critical patent/WO2003097072A1/ja
Priority to HK05108408A priority patent/HK1076385A1/xx
Publication of WO2003097072A9 publication Critical patent/WO2003097072A9/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

本発明は、効果的に肝斑を改善することができる肝斑改善用組成物、並びに皮膚のくすみを効果的に改善できるくすみ改善用組成物を提供することを目的とする。　プリン系核酸関連物質及び薬学的又は香粧的に許容される担体を含有する肝斑改善用組成物は、含有するプリン系核酸関連物質の肝斑改善作用に基づいて、優れた肝斑改善効果を奏することができる。また、プリン系核酸関連物質及び薬学的又は香粧的に許容される担体を含有するくすみ改善用組成物は、該組成物中のプリン系核酸関連物質の作用によって、優れたくすみ改善作用を発揮することができる。
PCT/JP2003/006175 2002-05-20 2003-05-19 肝斑改善用組成物及びくすみ改善用組成物 WO2003097072A1 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP03728092.2A EP1512405B1 (en) 2002-05-20 2003-05-19 Composition comprising adenosine monophosphate for treating melasma
JP2004505070A JP4425127B2 (ja) 2002-05-20 2003-05-19 肝斑改善用組成物及びくすみ改善用組成物
AU2003234818A AU2003234818B8 (en) 2002-05-20 2003-05-19 Chloasma amelioration composition and dullness amelioration composition
US10/514,833 US7994153B2 (en) 2002-05-20 2003-05-19 Chloasma amelioration composition and dullness amelioration composition
BR0311154-7A BR0311154A (pt) 2002-05-20 2003-05-19 Composição para melhorar o melasma e composição para reduzir a opacidade da pele
KR1020047018673A KR100948684B1 (ko) 2002-05-20 2003-05-19 기미 개선용 조성물 및 잡티 개선용 조성물
ES03728092T ES2428027T3 (es) 2002-05-20 2003-05-19 Composición que comprende adenosín-monofosfato para el tratamiento del melasma
CA2487789A CA2487789C (en) 2002-05-20 2003-05-19 Composition for improving melasma and composition for reducing skin dullness
HK05108408A HK1076385A1 (en) 2002-05-20 2005-09-23 Composition for improving melasma and composition for reducing skin dullness

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002-144735 2002-05-20
JP2002144735 2002-05-20

Publications (2)

Publication Number Publication Date
WO2003097072A1 WO2003097072A1 (ja) 2003-11-27
WO2003097072A9 true WO2003097072A9 (ja) 2009-02-19

Family

ID=29545062

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/006175 WO2003097072A1 (ja) 2002-05-20 2003-05-19 肝斑改善用組成物及びくすみ改善用組成物

Country Status (12)

Country Link
US (1) US7994153B2 (ja)
EP (2) EP1512405B1 (ja)
JP (1) JP4425127B2 (ja)
KR (1) KR100948684B1 (ja)
CN (1) CN1325056C (ja)
AU (1) AU2003234818B8 (ja)
BR (1) BR0311154A (ja)
CA (1) CA2487789C (ja)
ES (2) ES2633340T3 (ja)
HK (1) HK1076385A1 (ja)
TW (1) TW200408398A (ja)
WO (1) WO2003097072A1 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5093998B2 (ja) * 2004-09-22 2012-12-12 大塚製薬株式会社 色素沈着予防又は改善剤
FR2889956B1 (fr) * 2005-08-30 2012-04-20 Expanscience Lab Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
JP2008094811A (ja) * 2006-10-16 2008-04-24 Naris Cosmetics Co Ltd Ｏ／ｗ型乳化組成物及びその調製方法。
CA2694061C (en) * 2007-08-06 2015-11-03 Otsuka Pharmaceutical Co., Ltd. Gel composition for external application containing an adenine compound
CA2726890C (en) * 2008-06-03 2015-08-04 Otsuka Pharmaceutical Co., Ltd. Creamy o/w emulsion composition and production process thereof
JP5474663B2 (ja) * 2010-05-28 2014-04-16 第一三共ヘルスケア株式会社 肝斑判断支援システム
US8338348B2 (en) * 2010-12-21 2012-12-25 Johnson & Johnson Consumer Companies, Inc. Skin cleansing compositions with polyglycerol esters and hydrophobically modified polymers
DE102011077031A1 (de) * 2011-06-07 2012-12-13 Beiersdorf Ag Fettalkohol-freie kosmetische oder dermatologische Emulsionszubereitungen
DE102011077037A1 (de) * 2011-06-07 2012-12-13 Beiersdorf Ag Kosmetische oder dermatologische Lichtschutzzubereitung mit verbesserter Wasserfestigkeit
DE102011077042A1 (de) * 2011-06-07 2012-12-13 Beiersdorf Ag Haarkosmetische Zubereitungen umfassend Polyglyceryl-10-stearat
CN105520967B (zh) * 2014-09-28 2020-07-03 海运贸易有限公司 冬虫夏草提取液及其制备方法和应用
US9305929B1 (en) 2015-02-17 2016-04-05 Micron Technology, Inc. Memory cells
US10134982B2 (en) 2015-07-24 2018-11-20 Micron Technology, Inc. Array of cross point memory cells
WO2020217499A1 (ja) * 2019-04-26 2020-10-29 大塚製薬株式会社 アデノシンリン酸を含有するｏ／ｗ型低粘度乳化組成物
WO2020217503A1 (ja) * 2019-04-26 2020-10-29 大塚製薬株式会社 アデノシンリン酸を含有するｏ／ｗ型高粘度乳化組成物
DE202022104939U1 (de) 2022-09-01 2023-01-09 Sanjay Balasaheb Bhawar Polyherbale Creme für Melasma

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5421416B2 (ja) * 1973-04-09 1979-07-30
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
US5955109A (en) * 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
US4792443A (en) * 1985-12-20 1988-12-20 Warner-Lambert Company Skin bleaching preparations
US4946832A (en) * 1987-03-13 1990-08-07 R.I.T.A. Corporation Cosmetic base composition with therapeutic properties
JPS647541A (en) * 1987-06-30 1989-01-11 Toshiba Corp Manufacture of semiconductor device
JPH0195704A (ja) * 1987-10-08 1989-04-13 Masahiro Kobayashi シイタケ類の栽培具
US5160739A (en) * 1991-09-12 1992-11-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic composition
JPH05331142A (ja) 1992-05-26 1993-12-14 Shiseido Co Ltd 新規なアゼライン酸ピリジルアルキルジエステル誘導体およびそれらを含有した皮膚外用剤
DE4226174A1 (de) * 1992-08-07 1994-02-10 Solvay Fluor & Derivate Polyglycerinfettsäureestergemisch
FR2695034B1 (fr) * 1992-09-01 1994-10-07 Oreal Composition cosmétique ou pharmaceutique comprenant en association une peroxydase et un agent anti-oxygène singulet.
US5688831A (en) * 1993-06-11 1997-11-18 The Procter & Gamble Company Cosmetic make-up compositions
JP3661706B2 (ja) * 1993-10-28 2005-06-22 三省製薬株式会社 皮膚外用剤
JPH07277939A (ja) 1994-04-05 1995-10-24 Dowa Mining Co Ltd 皮膚外用剤
JPH0899860A (ja) * 1994-09-30 1996-04-16 Kose Corp 皮膚外用剤
JP3499616B2 (ja) 1994-10-20 2004-02-23 一丸ファルコス株式会社 ヒドロキシチロソール、メラニン生成抑制剤又は過酸化脂質生成抑制剤への応用
US5618522A (en) * 1995-01-20 1997-04-08 The Procter & Gamble Company Emulsion compositions
JPH09143093A (ja) * 1995-11-17 1997-06-03 Hoechst Japan Ltd 軟骨・骨誘導性修復用材料
JPH09143063A (ja) 1995-11-22 1997-06-03 Kose Corp 外用に適する組成物
JPH09183718A (ja) 1995-12-29 1997-07-15 Kose Corp 外用に適する組成物
JPH09234375A (ja) * 1996-03-01 1997-09-09 Mitsubishi Paper Mills Ltd 光反応性有害物除去材
JPH09249550A (ja) 1996-03-18 1997-09-22 Shiseido Co Ltd 皮膚外用剤
JPH09291011A (ja) * 1996-04-24 1997-11-11 Kose Corp 外用に適する組成物
DE69734498T2 (de) * 1996-05-20 2006-08-10 Shiseido Co. Ltd. Oel-in-wasser emulsion und oel-in-wasser emulgator
JPH107541A (ja) * 1996-06-20 1998-01-13 Noevir Co Ltd 皮膚外用剤
FR2751535B1 (fr) * 1996-07-25 1998-11-27 Oreal Utilisation de derives de la melatonine pour la la depigmentation de la peau et compositions les comprenant
JP3507635B2 (ja) * 1996-09-19 2004-03-15 株式会社コーセー 外用に適する組成物
JP3881411B2 (ja) * 1996-10-08 2007-02-14 株式会社コーセー 外用に適する組成物
US5998423A (en) * 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
JPH10182411A (ja) * 1996-12-26 1998-07-07 Kose Corp 皮膚外用剤
JPH10182412A (ja) * 1996-12-27 1998-07-07 Kose Corp 外用剤
JP3077625B2 (ja) * 1997-04-18 2000-08-14 住友金属工業株式会社 熱間圧延ロールの冷却方法
US5811112A (en) * 1997-05-30 1998-09-22 Chesebrough-Pond's Usa Co., Division Of Conopco Inc. Oil-in-water cosmetic emulsions containing a stabilized protease
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
JPH11269049A (ja) * 1998-03-23 1999-10-05 Yakult Honsha Co Ltd Ｏ／ｗエマルション型日焼け止め化粧料
EP0950407B1 (en) * 1998-04-14 2002-09-04 Hisamitsu Pharmaceutical Co., Inc. The use of a GP IIb/IIIa antagonist for the manufacture of a medicament suitable for transdermal application by iontophoresis
AU744295B2 (en) 1998-04-27 2002-02-21 Color Access, Inc. Composition and method for treatment of aging skin
FR2779637B1 (fr) * 1998-06-15 2000-09-01 Oreal Compositions cosmetiques photoprotectrices, contenant un nanopigment d'oxyde metallique et un terpolymere acrylique et utilisation de ces compositions pour proteger les matieres keratiniques contre le rayonnement ultraviolet
US6376481B2 (en) * 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
CA2347979C (en) * 1998-10-26 2009-01-06 University Of Massachusetts Treatment of skin with adenosine or adenosine analog
JP2000212025A (ja) 1999-01-21 2000-08-02 Shiseido Co Ltd 皮膚外用剤、美白化粧料およびメラニン生成抑制剤
JP2000212056A (ja) 1999-01-21 2000-08-02 Shiseido Co Ltd 皮膚外用剤、美白化粧料およびメラニン生成抑制剤
JP2000256188A (ja) * 1999-03-10 2000-09-19 Nikko Chemical Co Ltd 乳化組成物
MXPA01006553A (es) * 1999-12-14 2002-03-14 Avon Prod Inc Composicion pare el cuidado de la piel que media la comunicacion de celula a celula. .
TWI290472B (en) * 1999-12-17 2007-12-01 Kao Corp Cosmetic composition
AU2001250057A1 (en) * 2000-04-12 2001-10-30 Clairol Incorporated Cationic emulsifier-enhanced liquid crystal gel network based skin care moisturizing compositions
US20020034525A1 (en) * 2000-06-30 2002-03-21 Kao Corporation Skin cosmetic composition
AU2407902A (en) 2000-11-22 2002-06-03 Otsuka Pharma Co Ltd O/w emulsion composition and method of preparing the same
KR20080070782A (ko) 2001-04-13 2008-07-30 오츠카 세이야쿠 가부시키가이샤 당 흡수 촉진제
JP2002370986A (ja) 2001-04-13 2002-12-24 Otsuka Pharmaceut Co Ltd 糖取込促進剤
AU2003220857B2 (en) 2002-04-09 2009-01-29 Otsuka Pharmaceutical Co., Ltd. Composition for cell proliferation

Also Published As

Publication number Publication date
TW200408398A (en) 2004-06-01
KR20050007551A (ko) 2005-01-19
HK1076385A1 (en) 2006-01-20
EP1512405A1 (en) 2005-03-09
CA2487789A1 (en) 2003-11-27
ES2428027T3 (es) 2013-11-05
US7994153B2 (en) 2011-08-09
WO2003097072A1 (ja) 2003-11-27
CN1655800A (zh) 2005-08-17
EP1512405A4 (en) 2009-11-18
EP1512405B1 (en) 2013-08-14
BR0311154A (pt) 2005-03-29
AU2003234818A1 (en) 2003-12-02
AU2003234818B2 (en) 2009-03-12
CN1325056C (zh) 2007-07-11
US20050220827A1 (en) 2005-10-06
TWI316404B (ja) 2009-11-01
AU2003234818B8 (en) 2009-03-26
CA2487789C (en) 2012-04-03
JPWO2003097072A1 (ja) 2005-09-15
EP2517712B1 (en) 2017-05-10
KR100948684B1 (ko) 2010-03-18
ES2633340T3 (es) 2017-09-20
EP2517712A1 (en) 2012-10-31
JP4425127B2 (ja) 2010-03-03

Similar Documents

Publication Publication Date Title
WO2003097072A9 (ja) 肝斑改善用組成物及びくすみ改善用組成物
WO2004021968A3 (en) Solution for ungual application
HK1041436A1 (en) Use of nicotinic acid derivatives for the treatment of dna damae in skin cells.
AU2002327675A1 (en) Microneedles, microneedle arrays, and systems and methods relating to same
IL152486A0 (en) Alcohol-free cosmetic and pharmaceutical foam carrier
WO2007029187A3 (en) Use of protoberberines as an active substance regulating the pilosebaceous unit
AU4223300A (en) Systems and methods for electrosurgical removal of the stratum corneum
AU5210798A (en) Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
WO2005065269A3 (en) Compositions and method for decreasing the appearance of skin wrinkles
WO2001092477A3 (de) Dreidimensionales hautmodell
HK1067642A1 (en) Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs
AU2572499A (en) Human hairless gene, protein and uses thereof
WO2004021967A3 (en) Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
AU2001295850A1 (en) Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
WO2004009038A3 (de) Kosmetische zubereitungen mit antibakteriellen eigenschaften glyzyrrhetinsäure enthaltend
EP1582195A4 (en) BLEACHING, SKIN PREPARATION FOR OUTSIDE APPLICATION AND COSMETICS
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
PL368857A1 (en) Method and pharmaceutical preparations for reducing the activity of cells
AU6997200A (en) No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product
WO2001045650A3 (de) Kosmetische verwendung von rückständen aus der weinherstellung
AU2001247880A1 (en) Methods to prepare and use epidermal stem cells
WO2001062208A3 (de) Topische kosmetische mittel enthaltend 2-hydrazino-1,3-heteroazole
AU2001250933A1 (en) Chitosan formulation with azelaic acid and other actives for the treatment of acne
AU5487101A (en) Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA CN ID IN JP KR PH US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2487789

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004505070

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003234818

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020047018673

Country of ref document: KR

Ref document number: 10514833

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 20038114739

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 3692/DELNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 1-2004-501847

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 2003728092

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020047018673

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003728092

Country of ref document: EP